| abstract |
The present invention relates to compounds of formula (I), any of its enantiomers, or any mixture thereof, or a pharmaceutically acceptable acid addition salt thereof, wherein R?1, R2, R3, R4, R11, R12, R13, R14, and R15¿ each independently are hydrogen, alkyl, alkoxy, halogen, trifluoromethyl, nitro, cyano, amino, acyl, alkylamino, dialkylamino, aminocarbonyl, or acylamino; R5 is hydrogen, alkyl, alkoxyalkyl, or phenylalkyl; X is -CH¿2?-Z-, -Z-CH2-, -NH-CO-, -CO-NH-, or -CH=CH-; wherein Z is O, S, CH2 or NH; Y is O, -CH2-W-, -W-CH2-; wherein W is O, or S; and n is 0, 1, or 2. The compounds are useful in the treatment of psychotic disorders. |